Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sol-Gel Technologies Ltd 7 GOLDA MEIR ST WEIZMANN SCIENCE PARK NESS ZIONA L3 7403650 ISR

www.sol-gel.com Employees: 34 P: 972-8931-3429 F: 352-304-4444

Sector:

Medical

Description:

Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.

Key Statistics

Overview:

Market Capitalization, $K 121,265
Enterprise Value, $K 101,775
Shares Outstanding, K 2,786
Annual Sales, $ 11,540 K
Annual Net Income, $ -10,580 K
Last Quarter Sales, $ 400 K
Last Quarter Net Income, $ -5,940 K
EBIT, $ -10,230 K
EBITDA, $ -10,000 K
60-Month Beta 1.36
% of Insider Shareholders 66.51%
% of Institutional Shareholders 26.18%
Float, K 933
% Float 33.49%
Short Interest 19
Short Float 0.66%
Short Volume Ratio 0.23

Growth:

1-Year Return 344.27%
3-Year Return -4.54%
5-Year Return -55.54%
5-Year Revenue Growth -49.61%
5-Year Earnings Growth 69.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.13 on 11/20/25
Next Earnings Date 05/05/26
Earnings Per Share ttm -3.26
EPS Growth vs. Prev Qtr -151.08%
EPS Growth vs. Prev Year -2,030.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/05/25

SLGL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -33.61%
Return-on-Assets % -26.27%
Profit Margin % -91.68%
Debt/Equity 0.00
Price/Sales 10.42
Price/Cash Flow N/A
Price/Book 4.62
Book Value/Share 9.33
Interest Coverage -0.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar